UK Debt Pressures Spark IMF Bailout Fears – But Economists Say Rescue Is Unlikely
UK debt interest has soared to £111bn, fuelling headlines of an IMF bailout repeat. Experts say history is a warning but a 1976-style rescue is still unlikely.
UK debt interest has soared to £111bn, fuelling headlines of an IMF bailout repeat. Experts say history is a warning but a 1976-style rescue is still unlikely.
UK front pages 21 Aug 2025: Labour councils revolt over migrant hotels, new tax fears, rising inflation, and education inequality dominate headlines.
Labour unveils major infrastructure reform, giving ministers direct oversight of 50+ projects including Heathrow and rail upgrades to cut delays and boost growth.
Chancellor Reeves may replace stamp duty and outdated council tax with a fairer property tax on homes over £500K. Could this reshape UK housing?
The UK government is weighing inheritance tax reforms ahead of the autumn Budget, including caps on gifts, pension taxation, and reduced reliefs for farms and businesses.
Chancellor Rachel Reeves is preparing major inheritance tax and pension reforms to tackle a £40 billion budget shortfall. New proposals include capping lifetime gifts, tightening taper relief, and making unspent pensions subject to IHT from 2027 — changes aimed at boosting revenue without raising income tax, VAT, or National Insurance.
The UK faces a £51 billion budget shortfall, rising tax pressures, and director departures amid non-dom rule changes. Global trade tensions and US tariffs threaten further disruption to growth and public finances.
The 5p income tax rise is more than a think tank suggestion—it’s a coordinated signal. This opinion explores how the UK government may be preparing the public for a broken tax pledge.
The UK faces a potential Treasury deficit of up to £51 billion, with the Chancellor under pressure to raise taxes or cut spending in the Autumn Budget. Economists warn there is no easy path forward.
By Fidelis News | 16 July 2025 | UK News – Science & Industry The UK government has launched a major strategy aimed at strengthening its life sciences sector, with new measures designed to speed up clinical trials, attract investment, and accelerate drug innovation. While pharmaceutical leaders such as GSK, Moderna, and BioNTech welcomed the…